|
⚲
|
| Osprey Pharmaceuticals USA Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001436994 |
| Sale | 2009-05-18 ($9.0 M Offered, $5.9 M Sold) |
| Fund | |
| Phone | 4153626262 |
| Address | 425 California Street San Francisco, 94104 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Barbara Finck | |
| Jeanfrancois Pariseau | |
| Nassim Usman | |
| Jack Anthony | |
| Martial Lacroix | |
| John Hamer |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
ResultCare, Inc.
✚
|
0.0 | |
|
Retail Co-Invest Holdings 2, L.P.
✚
|
0.0 | |
|
R&F Real Estate Opportunity Fund LLC
✚
|
0.0 | |
|
RH Fund I, a series of Climate Capital Deals, LP
✚
|
0.0 | |
|
RH Fund I, a series of Cloud Capital Funds, LP
✚
|
0.0 | |
|
Rhinelander Mel
✚
|
0.0 | |
|
Rhythm Holding Company, LLC
✚
|
0.0 | |
|
Ricca Gregory James
✚
|
0.0 | |
|
Rice Energy Appalachia, LLC
✚
|
0.0 | |
|
REST Redux LLC
✚
|
0.0 |